title: Vemurafenib (Zelboraf) for metastatic melanoma.
mesh_terms: D000818:Animals; D002294:Carcinoma, Squamous Cell / Q000139:chemically induced / Q000201:enzymology / Q000556:secondary; D002986:Clinical Trials as Topic / Q000379:methods; D006801:Humans; D007211:Indoles / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D008545:Melanoma / Q000188:drug therapy* / Q000201:enzymology / Q000556:secondary*; D013449:Sulfonamides / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D000077484:Vemurafenib; D048490:raf Kinases / Q000037:antagonists & inhibitors* / Q000378:metabolism
chemical_list: D007211:Indoles; D013449:Sulfonamides; D000077484:Vemurafenib; D048490:raf Kinases